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ABSTRACT
Background. Reduced physical function is associated with an increased risk of mortality among patients with chronic kidney
disease (CKD) not requiring renal replacement therapy (RRT). Assessments of physical performance can help to identify
those at risk for adverse events. However, objective measures are not always feasible and self-reported measures may
provide a suitable surrogate.
Methods. We performed a cohort study examining associations between self-reported physical function and walking
behaviour with survival in patients with CKD not requiring RRT. Data were analysed from the QCKD study (Physical activity
opinions in kidney disease) (ISRCTN 87066351), a prospective observational mixed methods study of physical activity in
patients with CKD. A total of 450 patients with CKD not requiring RRT, ages 17–93 years, were followed up for a median of
43 months. Upon enrolment, participants completed two questionnaires: Duke Activity Status Index (DASI) (physical
function) and General Practice Physical Activity Questionnaire (GPPAQ) (habitual activity). Mortality data were collected
from electronic records in September 2016; RRT was considered a competing event.
Results. A total of 74 deaths occurred during follow-up and 101 participants were started on RRT. The adjusted subdistribution
hazard ratio (SHR) of mortality in participants scoring>19.2 on the DASI was 0.51 [95% confidence interval (CI) 0.30–0.88] while a
one-unit increase in the DASI was associated with an SHR of 0.97 (95% CI 0.95–0.99). The adjusted SHRs of mortality were 0.48
(95% CI 0.26–0.90), 0.25 (0.11–0.57) and 0.48 (0.23–0.80) for participants walking<1, 1–3 and3 h/week, respectively, compared with
no walking. A walking pace>3 mph was associated with a reduced risk of mortality [SHR 0.37 (95% CI 0.20–0.71)] compared with a
walking pace<3 mph.
Conclusions. Physical function and walking behaviours were independently associated with survival in CKD and may help
to identify patients at risk for adverse events.
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INTRODUCTION
Chronic kidney disease (CKD) is associated with reduced physi-
cal function, independent of age, gender and traditional vascu-
lar and cardiovascular risk factors [1]. Physical function refers to
an individual’s functional ability to perform activities of daily
living (ADLs), instrumental activities and other discretionary ac-
tivities [2]. Furthermore, reduced exercise capacity has been
shown to be a strong predictor of survival among ambulatory
patients with end-stage renal disease (ESRD) [3]. This is impor-
tant since a reduction in physical function is not exclusive to
haemodialysis patients but has also been demonstrated in
patients prior to requiring renal replacement therapy (RRT) [4].
When compared with age-matched controls, patients with CKD
have greater levels of impairment across all aspects of physical
function [5]. Roshanravan et al. [6] reported an association be-
tween reduced lower limb function (including gait speed and
timed up and go) and increased risk of mortality among patients
with CKD Stages 2–4. However, upper limb function assessed
using grip strength was not shown to be a significant predictor
of mortality.
Performing objective tests of physical performance, such as
those reported by Roshanravan et al. [6], may not always be clin-
ically applicable due to time and space constraints, and the
need for an observer to record measurements. In contrast, self-
reported measures may offer a more practical and cost-effective
way of assessing physical function. Patient-reported outcome
measures have the potential to assess the effect of declining
physical function on the ability to participate in ADLs, which is
often the prominent concern of patients [2]. The Duke Activity
Status Index (DASI) is a short 12-item validated patient-reported
outcome measure designed to assess functional capacity via an
individual’s ability to participate in life activities [7]. The DASI
was originally designed to assess physical function and aspects
of quality of life in patients with cardiovascular disease [7] but
has since been widely used in several clinical populations. This
includes patients with CKD not requiring RRT, where the DASI
has been shown to be reliable and have high agreement with
the gold standard measure of cardiorespiratory fitness [8].
Alternative measures of self-reported physical function, such as
the Human Activity Profile (HAP) and 36-item Short Form
Health Survey (SF-36), have been shown to correlate well with
performance measures in patients requiring dialysis treatment
[9], but to our knowledge they have not been validated as a mea-
sure of physical function in non-dialysis CKD patients.
Furthermore, the HAP is often criticized for its length (94 items)
and the time required to complete it [10]. When considering the
choice of outcome measures, certain factors should be taken
into consideration, including patient burden, accuracy of the
measure, cost and ability to implement the measure into rou-
tine practice [2]. The DASI is quick to complete, has been shown
to be an accurate measure in the target population and has the
potential to be distributed in large numbers and assess the
physical function of most patients at routine clinic appoint-
ments. However, currently it is unknown if a self-reported mea-
sure of physical function incorporating activities requiring both
upper and lower body strength is associated with adverse out-
comes in CKD patients.
Physical inactivity may contribute to reduced levels of physi-
cal function and exercise capacity in CKD, although the nature
of the relationship is likely to be bidirectional. Physical activity
refers to any movement produced by the skeletal muscles that
increases energy expenditure above resting [2], and is strikingly
low among CKD patients [11]. Evidence suggests that despite
guideline recommendations [9, 12], almost 60% of patients with
CKD are insufficiently active to experience health benefits [13].
Beddhu et al. [13] conducted a prospective follow-up analysis of
physical activity and mortality among patients with non-CKD
and CKD patients and reported that within the CKD cohort,
achieving physical activity goals set by international guidelines
was associated with a 56% reduction in mortality risk over a 7-
year follow-up. Patients with CKD often describe walking as
their preferred form of physical activity [14]; regular walking
has been shown to be cardioprotective [15] and is associated
with a reduced risk of RRT [16] and all-cause mortality among
CKD patients [16]. Furthermore, walking speed has been shown
to predict a decline in physical function, hospitalization and all-
cause mortality in ESRD [17]. However, the association between
walking behaviours and survival has not been explored previ-
ously among a UK CKD population. Based on the available liter-
ature, we hypothesize that better levels of self-reported
physical function (assessed by the DASI and self-reported walk-
ing pace) and greater volume of weekly walking will be associ-
ated with a reduced risk of mortality among non-dialysis CKD.
The aim of this study was to investigate if self-reported
physical function and walking behaviours are associated with
survival among patients with CKD not requiring RRT.
MATERIALS ANDMETHODS
We analysed data from the QCKD study (Physical activity opin-
ions in kidney patients; ISRCTN 87066351), a prospective obser-
vational mixed methods study of physical activity in patients
with CKD Stages 1–5 not requiring RRT. Participants were
recruited from a single-centre, secondary-care National Health
Service outpatient unit within the UK between September 2012
and June 2013.
Recruitment and inclusion
Participants were invited to participate by a researcher in the
outpatient clinic while awaiting their appointment. All patients
>18 years of age with CKD Stages 1–5 not requiring RRT were eli-
gible to participate. During the recruitment period we visited 54
outpatient clinics and approached 563 patients. This study was
approved by the National Research Ethics Service Committee
East Midlands–Northampton on 13 June 2012.
Procedures
Upon entry to the study, participants were asked to complete
a survey pack that included questionnaires assessing self-
reported levels of physical function and physical activity.
Demographic and clinical data including age, gender, ethnicity,
estimated glomerular filtration rate (eGFR; Modification of Diet
in Renal Disease equation), haemoglobin and comorbidities
were obtained from patient medical records. The extraction of
clinical data was performed in temporal proximity to question-
naire completion. Written consent was obtained prior to access-
ing medical records.
Self-reported physical function
Physical function was assessed via self-reports using the DASI.
This is a brief 12-item questionnaire that enquires about an
individual’s capability to complete ADLs [10]. Each activity is
weighted with a metabolic equivalent of tasks (METs) value,
which is then summed to produce a continuous measure
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ranging from 0 to 58.2. The DASI has previously been used in
patients with CKD not requiring RRT and has been shown to be
both a valid and reliable predictor of exercise capacity [8]. A
higher DASI score is associated with better physical
functioning.
Self-reported walking behaviours
The General Practice Physical Activity Questionnaire (GPPAQ) is
a screening tool used to classify individuals to one of four physi-
cal activity levels: inactive, moderately inactive, moderately ac-
tive or active [18]. However, certain subcategories within the
questionnaire such as walking, gardening, housework and
walking pace are not included in the classification system.
Instead, this relies on employment status, hours of gym work
and cycling. As the majority of participants in this study were of
retirement age, and walking is often cited as the most common
form of physical activity among CKD patients, we extracted
hours of walking and walking pace from the GPPAQ. As part of
the GPPAQ, participants were asked to report the number of
hours spent walking per week, including walking to work, shop-
ping and walking for pleasure. Responses were recorded cate-
gorically: none, some but <1, 1–3 or 3 h. In addition,
participants were asked to self-report their walking pace as
slow (<3 mph), steady, brisk or fast (>4 mph).
Outcome assessment
Mortality data were extracted from an electronic patient medi-
cal record used for renal patients in September 2016. Patient
records are routinely accessed and updated by the clinical team.
Time zero in the survival models was taken as the point where
patients were consented to the study and completed the survey
questions. Patients were right censored if they had not experi-
enced the event (death) at the time of data extraction (the end
of study); RRT was considered a competing risk event.
STATISTICAL ANALYSIS
Descriptive statistics were summarized as median [interquartile
range (IQR)] for continuous variables and percentages for cate-
gorical variables. Categorical variables, including hours of walk-
ing (0, <1, 1–3 and 3 h) and self-reported walking pace [slow
(<3 mph), steady, brisk and fast (>4 mph)] were extracted from
the GPPAQ. Due to the small number of participants reporting
brisk or fast walking, the categories were merged for analysis to
create two walking pace groups: <3 and 3 mph.
The main outcome of interest was mortality after study en-
rolment. We estimated the cumulative incidence function and
tested differences across categorical variables using a modified
log-rank test [19]. A receiver operating characteristics (ROC)
curve was constructed to plot the performance of the DASI con-
tinuous scores as a binary classifier for survival in order to iden-
tify a potential clinical marker for risk stratification. Sensitivity
and specificity analyses were performed to identify the best
cut-off score to predict mortality. We fitted Fine and Gray [20]
models to examine the association between physical function,
hours of walking per week, walking pace and mortality in both
unadjusted and adjusted models considering the competing
risk of RRT; the proportional subhazards assumption was tested
using Schoenfeld residuals. Models were constructed to explore
DASI scores as both binary and continuous variables. The mod-
els were then adjusted to control for the following covariates:
age, gender, ethnicity, eGFR, haemoglobin, diabetes mellitus,
hypertension and ischaemic heart disease. In addition, four
sensitivity analyses were conducted: (i) using a modified inclu-
sion criterion of CKD, that is, including only participants with
an eGFR <60 mL/min/1.73 m2; (ii) removing deaths within the
first 6 months to reduce the potential of reverse causation; (iii)
imputing missing data to generate 10 imputed datasets with
results combined using Rubin’s rules [21] and (iv) to estimate
mortality hazard ratios (HRs) for variables of interest a standard
Cox regression model was conducted, where competing events
were censored.
Assuming a binary variable (high versus low DASI score or
walking pace) with roughly equal numbers within each cate-
gory, a 90% survival in one group and 70% survival in the other
group, a significance of 0.05 and a log-rank test power of 90%,
an overall sample size of at least 178 participants was required.
Statistical analyses were performed using SPSS Statistics for
Windows, version 22 (IBM, Armonk, NY, USA) and Stata version
13 (StataCorp, College Station, TX, USA) [22]. Statistical signifi-
cance was accepted as a P-value <0.05 and results are reported
with 95% confidence intervals (CIs) unless stated otherwise.
RESULTS
Data from 450 participants were available for analysis (Figure 1
shows the flow of participants through the study). Follow-up
data were obtained covering a median of 43 (IQR 42–45) months.
During the follow-up period, 74 (16.4%) deaths occurred and 101
(22.4%) patients started RRT. The rate (per 1000 person-years)
was 58 for mortality and 79 for starting RRT. No patients were
lost to follow-up. Missing data for all variables of interest were
<5%. Participant characteristics are detailed in Table 1.
Cumulative incidence curves for self-reported physical func-
tion, walking pace and hours of walking are shown in Figure 2.
Associations between physical function and survival
Data on self-reported physical function were available for 450
participants, 74 of whom died over the follow-up period. The
ROC curve showed that a DASI score of 19.2 predicted mortality
with 60% sensitivity and 77% specificity [area under the curve
0.76 (95% CI 0.71–0.81), P< 0.001]. The rate (per 1000 person-
years) was 22 for patients scoring >19.2 and 36 for patients scor-
ing 19.2. After adjustment for age, gender, ethnicity, eGFR,
haemoglobin, hypertension, diabetes mellitus and ischaemic
heart disease, participants with a DASI score >19.2 had a lower
incidence of death [subdistribution hazard ratio (SHR) 0.51 (95%
CI 0.30–0.88)] (Table 2). When used continuously, a 1-unit higher
DASI was associated with a 3% reduction in mortality [SHR 0.97
(95% CI 0.95–0.99), P¼ 0.004] (Table 2).
Associations between hours of walking and survival
Data on the number of hours walked were available for 437 par-
ticipants, 70 of whom died over the follow-up period. Compared
with 0 h weekly, any amount of walking (<1, 1–3 and 3 h) was
associated with a reduced risk of mortality before and after ad-
justment (Table 2).
Associations between walking pace and survival
Self-reported walking pace data were available for 431 partici-
pants, 71 of whom died during the follow-up period. A self-
reported walking pace 3 mph was associated with a 63% lower
risk of death [SHR 0.37 (95% CI 0.20–0.71)] (Table 2).
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SENSITIVITY ANALYSES
Sensitivity analyses restricted to patients with an eGFR >60 mL/
min/1.73 m2, removing death in the first 6 months, imputing
missing values or using Cox HRs rather than a competing risk
model largely demonstrated a consistent pattern of results, par-
ticularly for the DASI as a continuous score and walking pace,
with associations seen with mortality across all models (Table 3).
DISCUSSION
Objective measures of physical performance have been shown
to associate with an increased risk of mortality [23]. This study
aimed to explore whether self-reported measures of physical
function and walking behaviours are associated with survival
among a CKD cohort not requiring RRT. We found that self-
reported physical function is independently associated with
mortality. Specifically, when using competing risk models for
RRT, self-reported levels of physical function indicated by a
DASI score >19.2 and walking pace >3 mph were associated
with a 49 and 63% reduced risk of mortality. This suggests that
the DASI score or self-reported walking pace may be a useful
prognostic factor when used alongside clinical and other known
risk markers for identifying patients who are at risk for adverse
outcomes. Using an equation previously validated in this popu-
lation [8], a DASI score of 19.2 equates to an estimated peak oxy-
gen consumption (VO2peak) score of 17.86 mL/min/kg, similar to
the median cut-off of 17.5 mL/min/kg reported by Sietsema et al.
[3] that predicted survival in a relatively healthy subset of ESRD
patients. Baseline VO2peak scores were determined by a stan-
dardized cycle ergometry exercise protocol and were shown to
significantly contribute to an explanatory model relating clini-
cal variables to mortality [3]. The DASI is a validated, quick and
simple measure of exercise capacity that has been widely uti-
lized within CKD research studies [24, 25] and could be incorpo-
rated relatively easily into routine clinical assessment.
FIGURE 1: Study flow diagram.
FIGURE 2: Cumulative incidence curves.
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Furthermore, the benefits of regular walking among patients
with CKD are well documented [26]. To our knowledge, this is
the first study to report the association between walking behav-
iours and survival in a UK CKD cohort. The results of this study
indicate that participants reporting 1–3 h of walking per week
had the greatest reduction in risk of mortality. Previous re-
search from a large observational study conducted in China in-
dicated that walking frequency was associated with survival
among patients with CKD Stages 3–5 [16], independent of age,
eGFR and comorbidities. The authors reported a relationship be-
tween walking frequency and lower mortality, however, they
did not specifically state the relationship between walking du-
ration and mortality. In our study, any reported walking activity
was associated with a reduction in mortality, with no clear evi-
dence of a dose–response relationship. The lack of a clear linear
dose response may be due to uncaptured confounders such as
exercise intensity and other known comorbidities, for example,
peripheral vascular disease and cerebrovascular disease. The
cross-sectional nature of the current study precludes our ability
to draw any conclusions regarding the dose–response
relationship between physical activity and mortality in patients
with CKD. However, a meta-analysis of 22 studies undertaken
in the general population showed that walking 2.5 h/week was
associated with a 19% reduction in all-cause mortality risk,
whereas walking 7 h/week was associated with an increase of
24% [27]. This indicated that the greatest benefits to health may
be found when encouraging patients to move from sedentary to
low levels of activity, although further health benefits were still
accrued from additional activity in patients reporting greater
levels of physical activity [28]. Further work, including walking
frequency, duration and intensity, is required to explore the
dose–response relationship in patients with CKD.
Gait speed is known to be associated with survival in older
adults [29] and patients with CKD [6]. However, objective meas-
ures of gait speed are not readily available in a clinical setting.
Therefore self-reported measures of walking pace may offer an
alternative that is quick and simple to complete and could be
easily implemented into routine clinical assessment. Recent ev-
idence has suggested that self-reported walking pace may pro-
vide a good surrogate measure of walking speed when direct
measurement is unavailable [30], while also being associated
with cardiorespiratory fitness and mortality within the general
population [31]. Our results suggest that patients who reported
a walking speed 3 mph had a reduced risk of mortality. Indeed,
the reduction in risk for walking pace was more pronounced
than the threshold of physical function (DASI score 19.2) derived
from this study, suggesting a simple self-reported walking pace
question could also be used to predict future morality risk in
CKD patients. Furthermore, in somewhat of a contradiction to
the relationship between physical activity and mortality, the as-
sociation between walking pace and risk of mortality has been
shown to be linear. Reasons for this are not fully understood,
however, faster walking pace may be an indicator of vitality and
multiple organ system function, thus offering a proxy measure
of overall health [29]. Roshanravan et al. [6] demonstrated in
fully adjusted models that for every 1-s increase on the timed
up and go, the risk of death increased by 8%. Slowness is also a
defining characteristic of frailty syndrome, which has been
shown to increase the risk of mortality [32]. However, further
Table 1. Baseline characteristics
Characteristics
Total
(N¼450)
Event-free
(n¼ 275)
RRT
(n¼ 101)
Deceased
(n¼ 74)
Age (years), median (IQR) 62 (48–75) 61 (45–73) 57 (48–68) 79 (68–83)
Gender (male), n (%) 258 (57) 147 (54) 60 (59) 51 (69)
Ethnicity (white), n (%) 360 (80) 226 (82) 63 (62) 71 (96)
eGFR (mL/min/1.73 m2), median, (IQR) 29 (19–54) 43 (27–74) 16 (11–19) 23 (17–34)
Haemoglobin (g/L), median (IQR) 122 (108–135) 129 (115–139) 111 (102–123) 114 (111–126)
Diabetes, n (%) 121 (27) 62 (23) 32 (32) 27 (37)
Hypertension, n (%) 247 (55) 128 (47) 77 (76) 42 (57)
Ischaemic heart disease, n (%) 82 (18.2) 36 (13) 18 (18) 28 (38)
DASI summed METs, median (IQR) 35.7 (18.95–50.70) 42.7 (23.45–58.2) 31.45 (15.45–50.2) 18.48 (9.95–28.7)
Walking hours (weekly), n (%)
0 86 (19) 32 (12) 19 (19) 35 (47)
<1 113 (25) 72 (26) 25 (25) 16 (22)
1–3 116 (26) 83 (30) 25 (25) 8 (11)
3 122 (27) 81 (30) 30 (30) 11 (15)
Missing 13 (3) 7 (3) 2 (2) 4 (5)
Walking pace
<3 mph 188 (42) 86 (31) 45 (45) 57 (77)
3 mph 243 (54) 177 (64) 52 (52) 14 (19)
Missing 19 (4) 12 (4) 4 (4) 3 (4)
Table 2. Competing risk analysis for mortality (n¼450)
Measures
Crude SHRs
(95% CI)
Adjusted SHRs
(95% CI)
DASI (0–58.2) (per 1-unit
increase)
0.95 (0.94–0.97)** 0.97 (0.95–0.99)**
DASI (>19.2 summed METs
versus 19.2)
0.24 (0.15–0.38)** 0.51 (0.30–0.88)*
Walking hours (weekly) (reference 0 h)
<1 0.30 (0.17–0.54)** 0.48 (0.26–0.90)*
1–3 0.14 (0.06–0.30)** 0.25 (0.11–0.57)**
3 0.18 (0.09–0.36)** 0.48 (0.23–0.80)*
Walking pace (reference <3 mph)
3 mph 0.17 (0.09–0.30)** 0.37 (0.20–0.71)**
Adjusted for age, gender, ethnicity, eGFR, haemoglobin, diabetes mellitus, hy-
pertension and ischaemic heart disease.
*P<0.05; **P<0.01.
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work is now required to determine if interventions targeting
walking pace are associated with improved outcomes in CKD
patients at risk of adverse events.
To our knowledge this is the largest CKD cohort utilized to
investigate the association between self-reported physical func-
tion and survival. However, this study is not without its limita-
tions. Due to the observational study design, caution should be
exercised when assigning a causal relationship between self-
reported physical function and walking behaviours and an in-
creased risk of mortality. Moreover, although we adjusted for
some factors (e.g. age, sex, haemoglobin), residual confounding
or confounding by unmeasured factors remains a possibility.
Data regarding causes of death were not obtainable, and as
such we were limited in our ability to perform additional analy-
ses regarding cardiovascular mortalities, which would have
been of interest. Furthermore, it remains unclear from this
study and the literature if positive changes to walking behav-
iour and physical function are associated with improved rates
of survival. Previous research has demonstrated that both phys-
ical function and physical activity in patients with CKD can be
successfully targeted via exercise [33] and behavioural interven-
tion [34]. Therefore further longitudinal and interventional
studies are required to assess the rate at which function
declines and how this associates with adverse outcomes, to in-
vestigate the effect of increasing levels of physical activity and
improving physical function on adverse events and to deter-
mine the optimal dose response for walking with regards to fre-
quency, duration and intensity associated with survival. In
addition, as with all self-reported data, there may be tendencies
for participants to over- or underestimate physical capabilities
and levels of physical activity. However, in the absence of objec-
tive assessment, we have shown that self-reported measures
can be incorporated into routine clinical assessment and help
to identify patients at risk of adverse events.
Self-reported physical function, hours of walking and walk-
ing pace are independent predictors of mortality in non-dialysis
CKD patients. This suggests that the DASI and self-reported
measures of walking behaviour, when used alongside clinical
information, may be a useful prognostic clinical tool to identify
participants at risk of adverse events.
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Table 3. Sensitivity analyses
1 2 3 4
Measures
Adjusted SHRs
(95% CI) P-value
Adjusted SHRs
(95% CI) P-value
Adjusted
SHRs (95% CI) P-value
Adjusted
HRs (95% CI) P-value
DASI (per 1-unit increase) 0.97 (0.95–0.99)** 0.003 0.97 (0.95–1.00)** 0.016 0.97 (0.95–0.99)** 0.011 0.97 (0.95–0.99)* 0.006
DASI (>19.2 summed METs
versus 19.2)
0.47 (0.27–0.83)** 0.009 0.56 (0.32–1.01) 0.054 0.53 (0.30–0.92)* 0.023 0.52 (0.30–0.90)* 0.019
Walking hours (weekly) (reference 0 h)
<1 0.43 (0.22–0.82)** 0.01 0.55 (0.29–1.05) 0.068 0.57 (0.30–1.10) 0.074 0.54 (0.29–1.00)* 0.049
1–3 0.24 (0.11–0.55)** 0.001 0.60 (0.28–1.27)** 0.002 0.30 (0.13–0.68)** 0.004 0.28 (0.12–0.62)* 0.002
3 0.44 (0.21–0.94)* 0.034 0.23 (0.09–0.58) 0.18 0.54 (0.27–1.09) 0.083 0.48 (0.23–1.00)* 0.051
Walking pace (reference <3 mph)
3 mph 0.35 (0.18–0.68)** 0.002 0.37 (0.19–0.74)** 0.005 0.40 (0.20–0.78)** 0.009 0.38 (0.20–0.72)* 0.003
Adjusted for age, gender, ethnicity, eGFR, haemoglobin, diabetes mellitus, hypertension and ischaemic heart disease.
Sensitivity analysis 1 (participants, n¼348; events, n ¼ 65): proportional subhazards model conducted for mortality after excluding patients with an eGFR>60 mL/min/
1.73 m2.
Sensitivity analysis 2 (participants, n¼441; events, n ¼ 65): proportional subhazards model conducted for mortality after excluding patients who died within the first
6 months after enrolment to the study.
Sensitivity analysis 3 (participants, n¼455; events, n ¼ 74): proportional subhazards model conducted for main analysis using multiple imputation to control for miss-
ing data.
Sensitivity analysis 4 (participants, n¼ 450; events, n ¼ 74): Cox proportional hazards model conducted for main analysis where competing events were censored.
*P<0.05; **P<0.01.
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